We are live on ! Find out more
CELU icon

Celularity

39 hedge funds and large institutions have $4.78M invested in Celularity in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

65% more capital inflows, than outflows

Capital inflows: $941K | Capital outflows: $571K

22% more call options, than puts

Call options by funds: $82K | Put options by funds: $67K

11% more funds holding

Funds holding: 35 → 39 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

0.48% less ownership

Funds ownership: 9.13% → 8.65% (-0.48%)

Holders
39
Holders Change
+4
Holders Change %
+11.43%
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
8
Increased
8
Reduced
8
Closed
4
Calls
$82​K
Puts
$67​K
Net Calls
+$15​K
Net Calls Change
-⁠$53​K

CELU Hedge Fund Activity: Q3 2025 in Review

39 of the 7,665 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q3 2025, worth a combined $4.78M — up 11% from $4.29M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new CELU positions and 4 closed out — a net gain of 4 holders — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Vanguard Group, adding an estimated $494K. The largest seller was Yorkville Advisors Global, cutting an estimated $280K.

  • 39 institutional investors held Celularity (CELU) as of Q3 2025, up from 35 in Q2 2025.
  • Funds reported $4.78M of Celularity stock for Q3 2025, up 11% quarter-over-quarter.
  • 8 funds opened new Celularity positions in Q3 2025 and 4 closed out, a net change of +4 holders.
  • The largest Celularity buyer in Q3 2025 was Vanguard Group, an estimated $494K added.
  • The largest Celularity seller in Q3 2025 was Yorkville Advisors Global, an estimated $280K sold.

Based on aggregated 13F filings for Q3 2025.